marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 02-27-2025
Xenon Pharmaceuticals Financial Ratios 2011-2025 | XENE
Annual Financial Ratios Xenon Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-12.8 | -17.2 | -19.6 | -15.0 | -17.2 | -9.3 | -4.6 | -1.8 | -5.4 | -6.0 | 4.3 | - | - | - |
P/S |
- | - | 260.1 | 64.2 | 15.4 | 56.7 | - | 179.3 | 69.2 | 6.1 | 2.0 | - | - | - |
EPS |
-3.0 | -2.7 | -2.1 | -1.8 | -0.8 | -1.5 | -1.6 | -1.7 | -1.5 | -1.1 | 4.1 | 2.9 | -3.2 | - |
EV (Enterprise Value) |
2.9 B | 3.02 B | 2.43 B | 1.03 B | 469 M | 418 M | 111 M | 45.5 M | 111 M | 38.7 M | -1.07 M | -7.58 M | -9.48 M | - |
EBITDA per Share |
-3.55 | -3.17 | -2.11 | -1.79 | -0.89 | -1.63 | -1.93 | -1.78 | -1.55 | -0.583 | 3.74 | - | - | - |
EV/EBITDA |
-13.1 | -14.9 | -8.9 | -2.8 | -1.3 | -4.5 | -4.3 | -1.3 | - | - | - | |||
PEG |
-0.47 | -0.79 | -1.46 | -1.18 | -0.67 | -1.69 | -0.99 | 0.12 | 0.16 | 0.05 | 0.02 | - | - | - |
P/B |
4.0 | 3.4 | 3.4 | 2.2 | 2.9 | 4.2 | 1.5 | 1.6 | 2.0 | 1.5 | 0.8 | - | - | - |
P/CF |
-16.5 | -20.7 | -24.3 | -17.0 | -10.3 | -65.9 | -4.5 | -1.9 | -6.3 | -5.1 | -44.6 | - | - | - |
ROE % |
-31.04 | -19.66 | -17.38 | -14.34 | -16.83 | -45.22 | -33.40 | -85.45 | -35.99 | -25.81 | 17.89 | - | - | - |
ROA % |
-29.36 | -18.90 | -16.62 | -13.79 | -15.24 | -28.16 | -28.18 | -66.57 | -34.08 | -24.63 | 14.89 | - | - | - |
ROCE % |
-37.00 | -23.07 | -17.90 | -14.36 | -18.27 | -41.05 | -32.13 | -77.49 | -38.79 | -15.30 | 15.19 | - | - | - |
Current Ratio |
18.5 | 26.2 | 23.1 | 26.0 | 10.6 | 3.3 | 29.5 | 11.0 | 18.7 | 21.9 | 5.9 | - | - | - |
DSO |
- | - | 72.6 | 45.4 | 15.0 | 43.5 | - | 514.1 | 40.5 | 7.4 | 2.8 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | 40.5 | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 72.6 | 45.4 | 14.9 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 72.6 | 45.4 | 14.9 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Xenon Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.81 | -0.75 | -0.62 | - | -0.73 | -0.72 | -0.63 | - | -0.57 | -0.55 | -0.35 | - | -0.36 | -0.51 | -0.42 | - | -0.25 | - | -0.22 | - | -0.33 | -0.37 | -0.42 | - | -0.63 | -0.45 | -0.21 | -0.45 | -0.43 | -0.41 | -0.42 | -0.34 | -0.51 | -0.42 | -0.23 | -0.27 | -0.27 | 0.08 | -0.64 | 0.14 | 2.67 | - | - | 1.87 | 0.99 | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.75 | - | - | - | -0.74 | - | -0.57 | -0.53 | -0.31 | - | -0.35 | -0.52 | -0.43 | - | -0.26 | -0.01 | -0.24 | - | -0.34 | -0.4 | -0.45 | - | -0.68 | -0.51 | -0.43 | -0.45 | -0.45 | -0.42 | -0.44 | -0.3 | -0.43 | -0.4 | -0.37 | -0.18 | - | 0.05 | -0.42 | - | 6.82 | 1.28 | 0.9 | 1.5 | 5.27 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-27.75 | -27.49 | -27.97 | -21.03 | -25.96 | -23.28 | -19.91 | -12.53 | -18.73 | -20.00 | -24.64 | -20.51 | -25.68 | -24.64 | -16.14 | -9.64 | -19.28 | -23.76 | -34.54 | -32.85 | -46.78 | -51.06 | -47.73 | -25.11 | -47.56 | -119.08 | -196.97 | -278.78 | -265.73 | -216.28 | -166.82 | -117.36 | -114.42 | -104.24 | -94.06 | -83.88 | -75.74 | -32.05 | 11.65 | 55.34 | 50.45 | 17.21 | -0.67 | -18.56 | -15.35 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-26.50 | -26.21 | -26.59 | -19.95 | -24.74 | -22.30 | -19.23 | -12.17 | -18.01 | -19.07 | -23.26 | -19.31 | -23.99 | -22.83 | -14.88 | -8.73 | -14.74 | -16.06 | -22.74 | -20.46 | -32.21 | -37.95 | -37.55 | -21.19 | -38.67 | -93.50 | -153.70 | -217.20 | -208.61 | -176.12 | -143.62 | -111.13 | -108.39 | -98.94 | -89.50 | -80.05 | -72.50 | -32.97 | 6.55 | 46.08 | 49.29 | 56.48 | 41.59 | 26.70 | 22.08 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-32.82 | -32.33 | -32.75 | -24.49 | -29.55 | -25.87 | -21.12 | -12.13 | -18.39 | -19.59 | -24.49 | -20.83 | -26.49 | -25.89 | -17.51 | -10.73 | -20.46 | -24.53 | -35.58 | -33.94 | -47.68 | -51.68 | -47.60 | -28.64 | -51.05 | -61.37 | -75.98 | -90.65 | -76.79 | -64.21 | -52.21 | -38.84 | -34.55 | -24.42 | -14.14 | -15.34 | -11.02 | 2.22 | 3.79 | 15.26 | 12.64 | -7.58 | -9.48 | -10.89 | -8.32 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
21.9 | 22.1 | 29.3 | 26.2 | 19.4 | 17.8 | 21.9 | 23.1 | 34.2 | 37.4 | 34.4 | 26.0 | 17.1 | 15.5 | 20.2 | 10.6 | 10.6 | 10.6 | 10.6 | 2.6 | 2.6 | 2.6 | 2.6 | 6.4 | 6.4 | 6.4 | 6.4 | 4.5 | 4.5 | 4.5 | 4.5 | 18.8 | 18.8 | 18.8 | 18.8 | 21.9 | 21.9 | 21.9 | 21.9 | 6.0 | 6.0 | 6.0 | 6.0 | 1.8 | 1.8 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | 1730.3 | 463.7 | 29.6 | - | 34.6 | 164.1 | 72.0 | - | 25.4 | 12.4 | 17.0 | - | 21.2 | - | - | - | - | - | - | 2498.0 | 151.4 | 2664.5 | 1819.3 | 48.5 | 44.2 | 44.2 | 39.1 | 8.9 | 6.7 | 7.1 | 6.0 | 4.0 | 1.5 | 3.7 | 6.0 | 7.2 | 1.9 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | 1730.3 | 463.7 | 29.6 | - | 34.6 | 164.1 | 72.0 | - | 25.4 | 12.4 | 17.0 | - | 21.2 | - | - | - | - | - | - | 2498.0 | 151.4 | 2664.5 | 1819.3 | 48.5 | 44.2 | 44.2 | 39.1 | 8.9 | 6.7 | 7.1 | 6.0 | 4.0 | 1.5 | 3.7 | 6.0 | 7.2 | 1.9 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | 1730.3 | 463.7 | 29.6 | - | 34.6 | 164.1 | 72.0 | - | 25.4 | 12.4 | 17.0 | - | 21.2 | - | - | - | - | - | - | 2498.0 | 151.4 | 2664.5 | 1819.3 | 48.5 | 44.2 | 44.2 | 39.1 | 8.9 | 6.7 | 7.1 | 6.0 | 4.0 | 1.5 | 3.7 | 6.0 | 7.2 | 1.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency